These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 13840401)

  • 1. Studies on blood factors RhA, RhB, and RhC.
    UNGER LJ; WIENER AS; KATZ L
    J Exp Med; 1959 Oct; 110(4):495-510. PubMed ID: 13840401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The half-life of passively acquired antibody globulin molecules in infants.
    WIENER AS
    J Exp Med; 1951 Sep; 94(3):213-21. PubMed ID: 14861379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of the quantitative antiglobulin test with serums of specificities anti-Rh O, anti-Rh A, anti-Rh B, anti-Rh C, and anti-Rh D.
    UNGER LJ; WEINER AS; KATZ L
    Am J Clin Pathol; 1959 Dec; 32():499-506. PubMed ID: 13840400
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic disease of the newborn due to both anti-Rh (D) and anti-Kell (K) antibodies.
    FRUMIN AM; KOHN A; WALDMAN S; GRAUB M
    Am J Obstet Gynecol; 1955 Sep; 70(3):663-5. PubMed ID: 13238515
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibodies to part of the Rho antigen complex occurring in two women with Rho variants.
    Zaino EC; Applewhaite F
    Transfusion; 1975; 15(3):256-9. PubMed ID: 805484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical re-examination of the specificity of auto-anti-Rh antibodies in patients with a positive direct antiglobulin test.
    Issitt PD; Pavone BG
    Br J Haematol; 1978 Jan; 38(1):63-74. PubMed ID: 416845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution of Rh groups in Denmark; typing of 7020 persons with anti-C and anti-D].
    LYNDRUP S
    Ugeskr Laeger; 1952 Nov; 114(46):1631-6. PubMed ID: 13029271
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and analysis of anti-Rh blood group antibodies].
    Wu YJ; Wu Y; Chen BC; Liu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jun; 24(6):604-6. PubMed ID: 18538092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Rh-o (D) positive patient whose serum contains anti-Rh-o (D) antibodies. Family studies.
    FRANCIS BJ; HATCHER DE; MARCUSE PM
    Vox Sang; 1960 Jul; 5():324-9. PubMed ID: 13701231
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency and specificity of red cell antibodies in thalassemia patients in Albania.
    Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G
    Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of maternal anti-Rh (anti-D) in an Rh-positive infant.
    NORRIS HJ; YUNIS E
    J Lancet; 1963 Jun; 83():243-4. PubMed ID: 13938968
    [No Abstract]   [Full Text] [Related]  

  • 12. [FREQUENCY OF ANTI-GM AND ANTI-D SERUMS ESSENTIAL TO THE DETERMINATION OF GM BLOOD GROUPS].
    AUDRAN R
    C R Hebd Seances Acad Sci; 1964 Nov; 259():4183-5. PubMed ID: 14260663
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-HrB and anti-hrb revisited.
    Pham BN; Peyrard T; Tourret S; Beolet M; Many H; Juszczak G; Roussel M; Kappler-Gratias S; Rouger P; Le Pennec PY
    Transfusion; 2009 Nov; 49(11):2400-5. PubMed ID: 19624490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The identification of dry blood spots. I. Research of the C, D and E factors of the Rhesus system. II. Demonstration of the irregular agglutinins anti-M, anti-D, and anti-C].
    RUFFIE J; DUCOS J
    Ann Med Leg Criminol Police Sci Toxicol; 1952; 32(5):351-61. PubMed ID: 13040842
    [No Abstract]   [Full Text] [Related]  

  • 15. INHIBITION OF AN ANTI-D BY A NORMAL SERUM FACTOR.
    FREIESLEBEN E; JENSEN KG
    Vox Sang; 1964; 9():65-9. PubMed ID: 14115409
    [No Abstract]   [Full Text] [Related]  

  • 16. The frequency of the occurrence of anti-D-B (anti-RhB) in anti-D(anti-Rh) sera.
    WARREN JK
    Vox Sang; 1962; 7():381-3. PubMed ID: 14005041
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on Rh antibodies; the demonstration of a third type of Rh antibody with blocking properties.
    MOHN JF; WITEBSKY E
    J Lab Clin Med; 1948 Nov; 33(11):1361-8. PubMed ID: 18890026
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL CONTRIBUTIONS ON THE DEMONSTRATION OF INCOMPLETE RH-ANTIBODIES. II. STATISTICAL EVALUATION OF VARIOUS SUPPLEMENTS IN THE DEMONSTRATION OF RH-ANTIBODY].
    SCHNEEWEISS B; LANGE A
    Z Kinderheilkd; 1964 Sep; 90():333-40. PubMed ID: 14316615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.